Category: Hong Kong Corporate News

Hong Kong Corporate News

Yeebo Announces Preliminary 2025 Losses for Suzhou QingYue, Up to RMB91 Million

Minichart

March 2, 2026

Yeebo (International Holdings) Limited: Key Highlights from ...

Continue Reading 0

Hong Kong Corporate News

Fortior Technology (Shenzhen) Issues Positive Profit Alert for 2025 with Strong Revenue and Asset Growth

Minichart

March 2, 2026

Fortior Technology (Shenzhen) Co., Ltd. Issues Positive Prof...

Continue Reading 0

Hong Kong Corporate News

Shanghai XNG Holdings Announces Termination of Placing Agreement for New Shares Under General Mandate 12

Minichart

March 2, 2026

Shanghai XNG Holdings Limited: Termination of Placing Agreem...

Continue Reading 0

Hong Kong Corporate News

Suzhou Ribo Life Science Announces Phase III Clinical Trial Initiation for RBD7022 siRNA Injection Targeting Hyperlipidemia in China 1

Minichart

March 2, 2026

Suzhou Ribo Life Science Announces Initiation of Phase III C...

Continue Reading 0

Hong Kong Corporate News

Contel Technology Faces Winding-Up Petitions Against Subsidiaries Over Alleged Debts in Hong Kong 1

Minichart

March 2, 2026

Contel Technology Company Limited: Winding-Up Petitions Agai...

Continue Reading 0

Hong Kong Corporate News

GenFleet’s GFH375 Receives Breakthrough Therapy Designation in China for KRAS G12D-Mutant NSCLC Treatment

Minichart

March 2, 2026

GenFleet Therapeutics Granted Breakthrough Therapy Designati...

Continue Reading 0

Hong Kong Corporate News

Tai Hing Group Announces Significant Profit Growth for FY2025 with Positive Profit Alert

Minichart

March 2, 2026

Tai Hing Group Holdings Issues Positive Profit Alert for FY2...

Continue Reading 0

Hong Kong Corporate News

HSBC Holdings plc Announces Senior Executives Share Sales – Suzanna White and Stuart Riley Transactions Disclosed

Minichart

March 2, 2026

HSBC Holdings plc - Notification of Significant Share Transa...

Continue Reading 0

Hong Kong Corporate News

Sino Biopharm’s Rovadicitinib Tablet Approved in China as First-Line Treatment for Myelofibrosis, Shows Superior Efficacy and Safety 12

Minichart

March 2, 2026

Sino Biopharmaceutical’s Rovadicitinib Tablet Approved for M...

Continue Reading 0

Hong Kong Corporate News

Global Corn Group Issues 2025 Profit Warning: Projects Net Loss Amid Revenue Decline and Market Challenges

Minichart

March 2, 2026

Global Corn Group Limited Issues Profit Warning for FY2025: ...

Continue Reading 0

Category: Hong Kong Corporate News

Join Our Investing Seminar